Anglais

Study involves identification of hereditary prostate cancer [HPC] susceptibility genes using a novel study design where whole-exome sequencing was undertaken on multiple affected relatives from 19 HPC families with 3 or more affected relatives diagnosed with clinically aggressive and/or early onset prostate cancer. Variables include subject ID, affection status, age, and duplicated samples of participants.

6 Formulaires  
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Study involves identification of hereditary prostate cancer [HPC] susceptibility genes using a novel study design where whole-exome sequencing was undertaken on multiple affected relatives from 19 HPC families with 3 or more affected relatives diagnosed with clinically aggressive and/or early onset prostate cancer. Variables include subject ID, consent group, affection status, and subject source of participants.
    3. Study involves identification of hereditary prostate cancer [HPC] susceptibility genes using a novel study design where whole-exome sequencing was undertaken on multiple affected relatives from 19 HPC families with 3 or more affected relatives diagnosed with clinically aggressive and/or early onset prostate cancer. Variables include family ID, father ID, mother ID, and sex of participants
    4. Study involves identification of hereditary prostate cancer [HPC] susceptibility genes using a novel study design where whole-exome sequencing was undertaken on multiple affected relatives from 19 HPC families with 3 or more affected relatives diagnosed with clinically aggressive and/or early onset prostate cancer. Variables include sample ID, subject ID, and sample source of participants.
    5. Study involves identification of hereditary prostate cancer [HPC] susceptibility genes using a novel study design where whole-exome sequencing was undertaken on multiple affected relatives from 19 HPC families with 3 or more affected relatives diagnosed with clinically aggressive and/or early onset prostate cancer. Variables include subject ID, affection status, age, and duplicated samples of participants.
    6. Study involve identification of hereditary prostate cancer [HPC] susceptibility genes using a novel study design where whole-exome sequencing was undertaken on multiple affected relatives from 19 HPC families with 3 or more affected relatives diagnosed with clinically aggressive and/or early onset prostate cancer. Variables include sample ID, body site of sample origin, analyte type, tumor or normal tissue, and primary tumor location associated with samples obtained from participants.
pht002202
Description

pht002202

De-identified subject ID
Description

SUBJID

Type de données

text

Alias
UMLS CUI [1,1]
C4684638
UMLS CUI [1,2]
C2348585
Affected or unaffected
Description

Affection_Status

Type de données

text

Alias
UMLS CUI [1,1]
C0871641
UMLS CUI [1,2]
C2986417
Age at diagnosis for affected relatives, age at last contact for unaffected relatives
Description

AGE

Type de données

text

Alias
UMLS CUI [1,1]
C1828181
UMLS CUI [1,2]
C0524348
UMLS CUI [2,1]
C0805839
UMLS CUI [2,2]
C2986417
UMLS CUI [2,3]
C0080103
Duplicate sample for subject sent to be used for QC purposes
Description

Duplicate_SAMP

Type de données

text

Alias
UMLS CUI [1,1]
C0205173
UMLS CUI [1,2]
C0370003
UMLS CUI [1,3]
C0034378
Retour au début de la page

Similar models

Study involves identification of hereditary prostate cancer [HPC] susceptibility genes using a novel study design where whole-exome sequencing was undertaken on multiple affected relatives from 19 HPC families with 3 or more affected relatives diagnosed with clinically aggressive and/or early onset prostate cancer. Variables include subject ID, affection status, age, and duplicated samples of participants.

6 Formulaires
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Study involves identification of hereditary prostate cancer [HPC] susceptibility genes using a novel study design where whole-exome sequencing was undertaken on multiple affected relatives from 19 HPC families with 3 or more affected relatives diagnosed with clinically aggressive and/or early onset prostate cancer. Variables include subject ID, consent group, affection status, and subject source of participants.
    3. Study involves identification of hereditary prostate cancer [HPC] susceptibility genes using a novel study design where whole-exome sequencing was undertaken on multiple affected relatives from 19 HPC families with 3 or more affected relatives diagnosed with clinically aggressive and/or early onset prostate cancer. Variables include family ID, father ID, mother ID, and sex of participants
    4. Study involves identification of hereditary prostate cancer [HPC] susceptibility genes using a novel study design where whole-exome sequencing was undertaken on multiple affected relatives from 19 HPC families with 3 or more affected relatives diagnosed with clinically aggressive and/or early onset prostate cancer. Variables include sample ID, subject ID, and sample source of participants.
    5. Study involves identification of hereditary prostate cancer [HPC] susceptibility genes using a novel study design where whole-exome sequencing was undertaken on multiple affected relatives from 19 HPC families with 3 or more affected relatives diagnosed with clinically aggressive and/or early onset prostate cancer. Variables include subject ID, affection status, age, and duplicated samples of participants.
    6. Study involve identification of hereditary prostate cancer [HPC] susceptibility genes using a novel study design where whole-exome sequencing was undertaken on multiple affected relatives from 19 HPC families with 3 or more affected relatives diagnosed with clinically aggressive and/or early onset prostate cancer. Variables include sample ID, body site of sample origin, analyte type, tumor or normal tissue, and primary tumor location associated with samples obtained from participants.
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
pht002202
SUBJID
Item
De-identified subject ID
text
C4684638 (UMLS CUI [1,1])
C2348585 (UMLS CUI [1,2])
Item
Affected or unaffected
text
C0871641 (UMLS CUI [1,1])
C2986417 (UMLS CUI [1,2])
Affection_Status
Code List
Affected or unaffected
CL Item
Unaffected (0)
CL Item
Affected (1)
AGE
Item
Age at diagnosis for affected relatives, age at last contact for unaffected relatives
text
C1828181 (UMLS CUI [1,1])
C0524348 (UMLS CUI [1,2])
C0805839 (UMLS CUI [2,1])
C2986417 (UMLS CUI [2,2])
C0080103 (UMLS CUI [2,3])
Item
Duplicate sample for subject sent to be used for QC purposes
text
C0205173 (UMLS CUI [1,1])
C0370003 (UMLS CUI [1,2])
C0034378 (UMLS CUI [1,3])
Duplicate_SAMP
Code List
Duplicate sample for subject sent to be used for QC purposes
CL Item
Original sample only (0)
CL Item
Duplicate sample (1)
Retour au début de la page